ZA927779B - Osmotic drug delivery devices with hydrophobic wall materials. - Google Patents

Osmotic drug delivery devices with hydrophobic wall materials.

Info

Publication number
ZA927779B
ZA927779B ZA927779A ZA927779A ZA927779B ZA 927779 B ZA927779 B ZA 927779B ZA 927779 A ZA927779 A ZA 927779A ZA 927779 A ZA927779 A ZA 927779A ZA 927779 B ZA927779 B ZA 927779B
Authority
ZA
South Africa
Prior art keywords
drug delivery
delivery devices
wall materials
osmotic drug
hydrophobic wall
Prior art date
Application number
ZA927779A
Other languages
English (en)
Inventor
Eun Soo Lee
Scott A Bura
Su Il Yum
Patrick S L Wong
Felix Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA927779B publication Critical patent/ZA927779B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
ZA927779A 1991-10-10 1992-10-09 Osmotic drug delivery devices with hydrophobic wall materials. ZA927779B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77563591A 1991-10-10 1991-10-10

Publications (1)

Publication Number Publication Date
ZA927779B true ZA927779B (en) 1993-07-05

Family

ID=25105009

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA927779A ZA927779B (en) 1991-10-10 1992-10-09 Osmotic drug delivery devices with hydrophobic wall materials.

Country Status (10)

Country Link
US (1) US5795591A (ja)
EP (1) EP0607321A1 (ja)
JP (1) JPH07500264A (ja)
AU (1) AU2867492A (ja)
CA (1) CA2115648C (ja)
MX (1) MX9205850A (ja)
NZ (1) NZ244682A (ja)
PT (1) PT100944B (ja)
WO (1) WO1993006819A1 (ja)
ZA (1) ZA927779B (ja)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022424A1 (en) * 1993-03-29 1994-10-13 Alza Corporation Biodegradable, water-permeable membrane for fluid-imbibing pump
EP0711146B1 (en) 1993-07-22 2000-09-06 Pfizer Inc. Osmotic device having a vapor-permeable coating
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
US6395292B2 (en) * 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
US6132420A (en) * 1996-02-02 2000-10-17 Alza Corporation Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
ZA9710342B (en) * 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
US5954966A (en) * 1997-01-31 1999-09-21 University Of Ottawa Membrane composition and method of preparation
ZA981610B (en) 1997-03-24 1999-08-26 Alza Corp Self adjustable exit port.
EP1325741B1 (en) * 1997-03-24 2007-06-06 Alza Corporation Implantable delivery device with self adjustable exit port
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
CN1161101C (zh) * 1998-12-17 2004-08-11 阿尔扎有限公司 用多层包衣将填充液体的明胶胶囊转变成控制释放的系统
US6491683B1 (en) * 1999-09-07 2002-12-10 Alza Corporation Osmotic dosage form composed of an extruded polymer tube form
DE60023361T2 (de) 1999-12-21 2006-04-27 Alza Corp., Mountain View Ventil für osmotische vorrichtungen
WO2001047498A2 (en) 1999-12-23 2001-07-05 Pfizer Products Inc. Hydrogel-driven layered drug dosage form comprising sertraline
SK8572002A3 (en) * 1999-12-23 2002-12-03 Pfizer Prod Inc Hydrogel-driven drug dosage form
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
AU2001273636A1 (en) * 2000-06-27 2002-01-08 Qualilife Pharmaceuticals Inc. Compositions and methods for treating females sexual response
MXPA03006217A (es) * 2001-01-12 2004-10-15 Sun Pharmaceutical Ind Ltd Sistema de administracion espaciada de farmacos.
EP1372753B1 (de) 2001-02-16 2007-08-01 Abbott Laboratories Vascular Enterprises Limited Implantate mit fk506 zur restenosebehandlung und -prophylaxe
RU2324475C2 (ru) * 2001-04-10 2008-05-20 Сан Фармасьютикал Индастриз Лимитед Состав, выделяемый в импульсном режиме в заданное время
US6632217B2 (en) * 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
EP1408876A4 (en) * 2001-06-22 2004-09-22 Durect Corp ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE
US6949154B2 (en) * 2001-07-28 2005-09-27 Boehringer Ingelheim Pharma Kg Method and apparatus for sealing medicinal capsules
MXPA04002476A (es) 2001-09-14 2004-05-31 Anthony A Boiarski Dispositivo de nanoporo microfabricado para la liberacion sostenida de agente terapeutico.
TWI222997B (en) * 2001-12-10 2004-11-01 Ind Tech Res Inst Method for tissue culture in vitro
EP1536767B1 (en) * 2002-06-17 2007-08-08 Alza Corporation Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
EP1551493B1 (en) * 2002-06-26 2007-10-31 Alza Corporation Minimally compliant, volume efficient piston for osmotic drug delivery systems
AU2003250913A1 (en) * 2002-07-08 2004-01-23 Abbott Laboratories Vascular Enterprises Limited Drug eluting stent and methods of manufacture
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US7037521B2 (en) * 2003-03-28 2006-05-02 Bausch & Lomb Incorporated Using a laser for cutting a hole in a capsule for controlled drug delivery
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
AU2005269988B2 (en) 2004-07-02 2012-02-02 Mati Therapeutics Inc. Treatment medium delivery device and methods for delivery
US7117870B2 (en) * 2004-07-26 2006-10-10 Clarity Corporation Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
DE102004042578A1 (de) * 2004-09-02 2006-03-23 Roche Diagnostics Gmbh Mikropumpe zur Förderung von Flüssigkeiten mit niedrigen Förderraten im Druck/Saug-Betrieb
DE102005001332A1 (de) * 2005-01-11 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
US20080009423A1 (en) 2005-01-31 2008-01-10 Halliburton Energy Services, Inc. Self-degrading fibers and associated methods of use and manufacture
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US8801694B2 (en) * 2005-08-11 2014-08-12 Massachusetts Institute Of Technology Intravesical drug delivery device
DK2020990T3 (da) 2006-05-30 2010-12-13 Intarcia Therapeutics Inc Strømningsmodulator med en indre kanal til et todelt osmotisk fremføringssystem
EP2049081B1 (en) 2006-08-09 2012-11-14 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
JP2010511627A (ja) * 2006-11-30 2010-04-15 エーシーシーユー−ブレイク テクノロジーズ，インク． 分割可能な浸透性剤形及びその使用方法
CN101715340A (zh) 2007-04-23 2010-05-26 精达制药公司 促胰岛素释放肽的混悬制剂及其应用
EP2231254B9 (en) * 2007-12-11 2015-04-08 Massachusetts Institute of Technology Implantable drug delivery device
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
EP2328628A2 (en) 2008-08-09 2011-06-08 Massachusetts Institute of Technology Implantable drug delivery device and methods of treating male genitourinary and surrounding tissues
CN102481438B (zh) 2009-06-26 2013-09-18 塔里斯生物医药公司 可植入药物递送装置及制造所述装置的方法
CN109157742B (zh) 2009-08-03 2022-04-05 因卡伯实验室有限责任公司 用于刺激肠道内肠促胰岛素产生的吞咽式囊和方法
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
JP5718925B2 (ja) 2009-09-28 2015-05-13 インターシア セラピューティクス，インコーポレイティド 実質的な定常状態薬物送達の迅速な確立及び／又は停止
US8679094B2 (en) * 2009-12-17 2014-03-25 Taris Biomedical, Inc. Implantable device with intravesical tolerability and methods of treatment
US8759284B2 (en) * 2009-12-24 2014-06-24 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8764733B2 (en) 2010-12-23 2014-07-01 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9284367B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809271B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9861683B2 (en) * 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8846040B2 (en) 2010-12-23 2014-09-30 Rani Therapeutics, Llc Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10639272B2 (en) 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US8980822B2 (en) 2010-12-23 2015-03-17 Rani Therapeutics, Llc Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
EP2663300B1 (en) 2011-01-10 2023-03-08 TARIS Biomedical LLC Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
EP2670398B1 (en) 2011-02-04 2017-06-07 TARIS Biomedical LLC Implantable device for controlled release of low solubility drug
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
AU2014232801B2 (en) 2013-03-15 2019-01-17 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
ES2817838T3 (es) 2013-08-19 2021-04-08 Taris Biomedical Llc Dispositivos de administración de fármacos de unidades múltiples
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR102658706B1 (ko) 2015-04-23 2024-04-17 타리스 바이오메디컬 엘엘씨 약물-투과성 성분을 구비한 약물 전달 장치 및 방법
WO2016196112A1 (en) * 2015-05-29 2016-12-08 Zebrasci, Inc. Biopolymer-based emulsion lubricants for syringe barrels
WO2016196851A2 (en) 2015-06-03 2016-12-08 Intarcia Therapeutics, Inc. Implant placement and removal systems
WO2017200943A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
US20190298771A1 (en) 2016-09-28 2019-10-03 Atossa Genetics Inc. Methods of adoptive cell therapy
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991766A (en) * 1973-05-31 1976-11-16 American Cyanamid Company Controlled release of medicaments using polymers from glycolic acid
US4093708A (en) * 1974-12-23 1978-06-06 Alza Corporation Osmotic releasing device having a plurality of release rate patterns
US4034758A (en) * 1975-09-08 1977-07-12 Alza Corporation Osmotic therapeutic system for administering medicament
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4111203A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4220153A (en) * 1978-05-08 1980-09-02 Pfizer Inc. Controlled release delivery system
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4400374A (en) * 1979-06-22 1983-08-23 Environmental Chemicals, Inc. Controlled release of compounds utilizing a plastic matrix
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
DK90883A (da) * 1982-03-18 1983-09-19 Merck & Co Inc Beholder til osmotisk afgivelse af et stof eller en stofblanding
US4552752A (en) * 1983-01-31 1985-11-12 Rohm And Haas Company Microbiocidal article for aqueous systems
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4656057A (en) * 1983-07-28 1987-04-07 Rohm And Haas Company Microbiocidal article for aqueous systems
US4751071A (en) * 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
US4968507A (en) * 1984-06-20 1990-11-06 Merck & Co., Inc. Controlled porosity osmotic pump
US5008112A (en) * 1985-12-16 1991-04-16 International Minerals & Chem. Corporation Device for the extended delivery of diffusible agents
US5145945A (en) * 1987-12-17 1992-09-08 Allied-Signal Inc. Homopolymers and copolymers having recurring carbonate units
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US5034229A (en) * 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5223266A (en) * 1990-01-24 1993-06-29 Alza Corporation Long-term delivery device with early startup

Also Published As

Publication number Publication date
PT100944B (pt) 2000-02-29
CA2115648A1 (en) 1993-04-15
PT100944A (pt) 1994-06-30
NZ244682A (en) 1993-12-23
JPH07500264A (ja) 1995-01-12
EP0607321A1 (en) 1994-07-27
CA2115648C (en) 2002-04-09
MX9205850A (es) 1993-06-01
AU2867492A (en) 1993-05-03
WO1993006819A1 (en) 1993-04-15
US5795591A (en) 1998-08-18

Similar Documents

Publication Publication Date Title
ZA927779B (en) Osmotic drug delivery devices with hydrophobic wall materials.
US5525634B1 (en) Colonic drug delivery system
GR3018890T3 (en) Medicament dispensing device.
EP0670716A4 (en) TASTE-MASKED PHARMACEUTICAL SUBSTANCES.
ZA926020B (en) Pharmaceutical combination formulation.
AU2937892A (en) Polymer-based osmotic drug delivery system
IL109661A0 (en) Drug delivery device
EP0662851A4 (en) DRUG DELIVERY SYSTEM.
GR3036937T3 (en) Pharmaceutical formulations.
DE69427472D1 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
ZA927562B (en) Medicament.
ZA936621B (en) Medicament dispensing device.
EP0523943A3 (en) Pharmaceutical container
GB9117717D0 (en) Dispenser pumps
EP0523942A3 (en) Pharmaceutical container
GB9021094D0 (en) Liquid delivery systems
EP0613445A4 (en) DISTRIBUTOR.
ZA929294B (en) Syringe.
DE69217020D1 (de) Arzneimittel mit gesteuerter Wirkstoffabgabe
ZA927506B (en) New drug formulation.
GB9109021D0 (en) Dosing pump
ZA929724B (en) Ballisitc materials.
GB9104226D0 (en) Liquid delivery system
EP0600754A3 (en) Continuous flow pharmaceutical transfusion.
EP0641193A4 (en) CHEMOTHERAPEUTIC DRUG COMBINATIONS.